Delayed clearance of apoptotic lymphoma cells allows cross-presentation of intracellular antigens by mature dendritic cells

P Rovere, MG Sabbadini, C Vallinoto… - Journal of leukocyte …, 1999 - academic.oup.com
Single cells are deleted from the midst of living tissue during normal turnover and embryogenesis.
This event is not associated with inflammation or autoimmunity. Little is known of the …

The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells

…, C Garlanda, U Fascio, MG Sabbadini… - Blood, The Journal …, 2000 - ashpublications.org
Pentraxins are acute-phase proteins produced in vivo during inflammatory reactions. Classical
short pentraxins, C-reactive protein, and serum amyloid P component are generated in …

PTX3 in small‐vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation

…, L Praderio, G Ciboddo, MG Sabbadini… - … : Official Journal of …, 2001 - Wiley Online Library
Objective To verify whether the prototypical long pentraxin PTX3 represents an indicator of
the activity of small‐vessel vasculitis. Methods Concentrations of PTX3, a pentraxin induced …

The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases

…, A Berti, C Campochiaro, MG Sabbadini… - Annals of the …, 2013 - ard.bmj.com
Objectives Erdheim–Chester disease (ECD) is a rare inflammatory disorder characterised
by organ infiltration by non-Langerhans’ histiocytes. Although rare, ECD is clearly an …

Pentraxin-3 as a marker of disease activity in Takayasu arteritis

…, AA Manfredi, E Baldissera, MG Sabbadini - Annals of internal …, 2011 - acpjournals.org
Background: Because pentraxin-3 (PTX3) is produced by immune and vascular cells in
response to proinflammatory signals, it may be a useful biomarker for defining disease activity in …

Efficacy of traditional and biologic agents in different clinical phenotypes of adult‐onset Still's disease

…, P Aiello, E Baldissera, MG Sabbadini - Arthritis & …, 2010 - Wiley Online Library
Objective To evaluate the efficacy of antiinflammatory agents, steroids, immunosuppressants,
and biologic agents in patients with adult‐onset Still's disease (AOSD) who have either …

BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease

…, A Von Deimling, MG Sabbadini, M Ferrarini… - Annals of the …, 2015 - ard.bmj.com
Objectives Erdheim-Chester disease (ECD) is a rare form of histiocytosis characterised by
uncontrolled chronic inflammation. The oncogenic BRAF V600E mutation has been reported …

Apoptotic cell clearance in systemic lupus erythematosus: I. Opsonization by antiphospholipid antibodies

…, G Balestrieri, A Tincani, MG Sabbadini - … : Official Journal of …, 1998 - Wiley Online Library
Sabbadini‘s work was supported by a MURST hO% grant. Dr. Rovere is the recipient of a
Mario and Valeria Rindi fellowship from the Fondazione Italiana per la Ricerca sul Cancro. …

Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim‐Chester disease: implications for pathogenesis

…, M Tresoldi, AA Beretta, MG Sabbadini - … : Official Journal of …, 2006 - Wiley Online Library
Objective Erdheim‐Chester disease (ECD) is a rare form of non–Langerhans' cell histiocytosis
(LCH) of unknown etiology, characterized by diffuse histiocyte infiltration of bones and …

Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia

…, L Valsecchi, C Lanzani, MG Sabbadini… - Obstetrics & …, 2006 - journals.lww.com
OBJECTIVE: Cell death normally occurs during pregnancy and is critical during its common
complication, preeclampsia. The long pentraxin 3 (PTX3) gene is generated in tissues that …